{"id":8360,"date":"2023-10-26T14:21:38","date_gmt":"2023-10-26T12:21:38","guid":{"rendered":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2023\/10\/231026_EN_MaaT-Pharma.pdf"},"modified":"2023-10-26T14:21:38","modified_gmt":"2023-10-26T12:21:38","slug":"231026_en_maat-pharma","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/pharma-announces-positive-outcome-following-dsmb-review-reinforcing-confidence-in-phase-3-on-going-trial\/231026_en_maat-pharma\/","title":{"rendered":"231026_EN_MaaT-Pharma"},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-8360","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"\n